About Arrogene

About company

Arrogene is a developer of a cancer medical technology designed to create a new generation of nano agents capable of delivering peptide, protein, and oligonucleotide therapeutics across the blood-brain barrier. The company's technology offers a unique nano-medicine platform that delivers multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer, enabling patients to prevent tumor growth for imaging.